Course detailHarvardEmerging / Needs Reviewopen

BIOT E-125

Financial Analysis and Valuation in Biotechnology

Harvard University presents Financial Analysis and Valuation in Biotechnology, a cutting-edge course in the Emerging / Needs Review category.

This program offers an in-depth exploration of financial methodologies specific to the biotechnology sector, equipping students with the analytical tools needed for investment decisions and valuation techniques.

Participants will gain expertise in assessing biotech firms, understanding market dynamics, and applying financial models to real-world scenarios in this rapidly evolving field.

Schedule note
T 8:10pm - 10:10pm Jan 24 to May 14

Help keep the register running.

Every cup of coffee fuels the sync workers and proxy rotations.

Buy me a coffee